Martin Meglasson
2008 - Ligand Pharmaceuticals
In 2008, Martin Meglasson earned a total compensation of $684.7K as Vice President, Discovery Research at Ligand Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $94,862 |
|---|---|
| Option Awards | $173,856 |
| Salary | $316,207 |
| Stock Awards | $95,473 |
| Other | $4,322 |
| Total | $684,720 |
Meglasson received $316.2K in salary, accounting for 46% of the total pay in 2008.
Meglasson also received $94.9K in non-equity incentive plan, $173.9K in option awards, $95.5K in stock awards and $4.3K in other compensation.
Rankings
In 2008, Martin Meglasson's compensation ranked 5,539th out of 9,135 executives tracked by ExecPay. In other words, Meglasson earned more than 39.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,539 out of 9,135 | 39th |
Division Manufacturing | 2,019 out of 3,436 | 41st |
Major group Chemicals And Allied Products | 419 out of 815 | 49th |
Industry group Drugs | 267 out of 597 | 55th |
Industry Pharmaceutical Preparations | 197 out of 408 | 52nd |
Source: SEC filing on April 29, 2009.
Meglasson's colleagues
We found four more compensation records of executives who worked with Martin Meglasson at Ligand Pharmaceuticals in 2008.